163 related articles for article (PubMed ID: 6425226)
21. Comparative labelling and biokinetic studies of 99mTc-EDTA(Sn) and 99mTc-DTPA(Sn).
Agha N; Persson RB
Nuklearmedizin; 1977 Feb; 16(1):30-5. PubMed ID: 403509
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
[TBL] [Abstract][Full Text] [Related]
23. A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. I: Radiochemical and animal distribution studies.
Galli G; Maini CL; Orlando P; Deleide G; Valle G
J Nucl Med Allied Sci; 1988; 32(2):110-6. PubMed ID: 3049961
[No Abstract] [Full Text] [Related]
24. Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99mTc]-DTPA-DG) as a potential imaging modality for tumors.
Chen Y; Huang ZW; He L; Zheng SL; Li JL; Qin DL
Appl Radiat Isot; 2006 Mar; 64(3):342-7. PubMed ID: 16290170
[TBL] [Abstract][Full Text] [Related]
25. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
[TBL] [Abstract][Full Text] [Related]
26. Labeling of penicillamine di sulfide with technetium-99m.
Unak P; Tunç M; Duman Y
Appl Radiat Isot; 1998 Jul; 49(7):805-9. PubMed ID: 9570099
[TBL] [Abstract][Full Text] [Related]
27. Brain scintigraphy with 99mTc-citrate and 99mTc-DTPA: a clinical comparison of the results.
Castagnoli A; Pupi A; Guizzardi G; Ferri P; Taverni N; Meldolesi U; Formiconi A
Eur J Nucl Med; 1982; 7(4):184-6. PubMed ID: 7042348
[No Abstract] [Full Text] [Related]
28. Radical scavengers and the stability of 99mTc-radiopharmaceuticals.
Berger R
Int J Appl Radiat Isot; 1982 Dec; 33(12):1341-4. PubMed ID: 7169269
[TBL] [Abstract][Full Text] [Related]
29. The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.
Van den Brand JA; Das HA; Dekker BG; de Ligny CL; Van den Hamer CJ
Int J Appl Radiat Isot; 1982 Oct; 33(10):917-28. PubMed ID: 6818161
[TBL] [Abstract][Full Text] [Related]
30. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
31. Indirect spectrophotometric determination of BIDA, DISIDA, DTPA and MDP in labelled compounds.
van der Walt TN; Coetzee PP; Fourie PJ
Int J Rad Appl Instrum A; 1989; 40(6):525-9. PubMed ID: 2551849
[TBL] [Abstract][Full Text] [Related]
32. Preparation, quality control and application of 99mTc-gluco-ene-diolate for renal scanning.
Shafiq YF; Al-Janabi MA
Nuklearmedizin; 1985 Apr; 24(2):93-5. PubMed ID: 4022788
[TBL] [Abstract][Full Text] [Related]
33. [The differential use of 99mTc-DTPA and 99mTc-MAG3 in the aftercare of kidney transplant patients].
Kotzerke J; Burchert W; Ringe B; Hundeshagen H
Rofo; 1990 Feb; 152(2):241-2. PubMed ID: 2155467
[No Abstract] [Full Text] [Related]
34. A new method for radiolabeling of Gelfoam particles with 99mTc.
Karesh SM; Spigos DG; Tan WS; Pavel DG
Int J Appl Radiat Isot; 1982 Dec; 33(12):1415-21. PubMed ID: 6220980
[TBL] [Abstract][Full Text] [Related]
35. Clinical comparison of technetium-99m-N,N-bis(mercaptoacetyl)-2,3-diaminopropanoate with technetium-99m DTPA for renal imaging.
Kuni CC; Klingensmith WC; Fritzberg AR; Spitzer VM; Latteier JL
Clin Nucl Med; 1985 Nov; 10(11):810-3. PubMed ID: 3935354
[TBL] [Abstract][Full Text] [Related]
36. Time course of 99mTc-pyrophosphate and 99mTc-gluconate uptake in experimental ischaemic myocardial necrosis.
Kasalický J; Riedel A; Konopková M
Radiobiol Radiother (Berl); 1985; 26(5):641-50. PubMed ID: 3003790
[No Abstract] [Full Text] [Related]
37. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
38. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
[TBL] [Abstract][Full Text] [Related]
39. Direct labeling of proteins with 99mTc.
Rhodes BA
Int J Rad Appl Instrum B; 1991; 18(7):667-76. PubMed ID: 1787075
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
